| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |